MedPath

ADDED EFFECT OF ORAL ADMINISTRATION OF BAKUCHI CHURNA OVER TOPICAL APPLICATION OF GAJALINDALEPA IN THE MANAGEMENT OF VITILIGO IN CHILDRE

Not Applicable
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2020/03/023946
Lead Sponsor
SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL HASSA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.The children of either gender between the age group of 6-16 years fulfilling the diagnostic criteria of Vitiligo.

2.Children, whose parents are willing to participate them in the study after giving informed parental consent.

Exclusion Criteria

1.Vitiligo patches developed as a complication of burns.

2.Children diagnosed with autoimmune disorders, neurological disorders, endocrine disorders, leprosy and tuberculosis.

3.Children with universal vitiligo and mucosal vitiligo.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath